BSE filing, NSE: KEI. Summary written from the filing by ALFA Finder's alert engine.
KEI Industries Ltd: key numbers
- Share price
- ₹3,856.00
- Market cap
- ₹36,881 Cr
- Revenue (annual)
- ₹11,748 Cr
- Net profit (annual)
- ₹918.4 Cr
- P/E (TTM)
- 34.9×Sector 41.7×
- Promoter holding
- 35.00%+0.00% QoQ
- FII holding
- 26.14%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from KEI Industries Ltd
All →KEI Industries Earnings Call Transcript: Key Takeaways
KEI delivered robust 38% revenue growth led by domestic demand, yet margins saw slight contraction.
- Call
- Guides 25% growth
KEI Industries Investor Presentation: Key Takeaways
KEI reports strong Q2 FY27 with revenue growing 38.5% YoY to ₹3,777 Cr, driven by robust domestic Wires & Cables demand. PAT rose 29% YoY to ₹262 Cr.
KEI Industries Q2 FY27 Results: Net Profit ₹262.4 Cr, Up 28.9% YoY
KEI Industries Ltd reported revenue from operations of ₹3,776 Cr (+38.5% YoY) and net profit of ₹262.4 Cr (+28.9% YoY) for Q2 FY27.
- Key figure
- Net profit ₹262.4 Cr · +28.9% YoY
KEI Industries Other Announcement
KEI Industries reported an ESG rating of '71' (Excellent category) assigned by an external agency, noting it did not commission this independent report.
KEI Industries Board Meeting Date
KEI Industries has scheduled its Board meeting for 21 October 2026 to review Q1 and H1 FY27 results. The trading window remains closed until 23 October 2026.
KEI Industries Capital Structure Change
KEI Industries Limited allotted equity shares under its ESOP/ESPS scheme. This capital structure change increases the company's paid-up share capital.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.